Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00006040
Status:
COMPLETED
Last Update Posted:
2013-06-19
First Post:
2000-07-05
Brief Title:
Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Leukemia |
| Myelodysplastic Syndromes |
| MyelodysplasticMyeloproliferative Neoplasms |
Keywords:
| Name | View |
|---|---|
| recurrent adult acute myeloid leukemia | View |
| recurrent adult acute lymphoblastic leukemia | View |
| relapsing chronic myelogenous leukemia | View |
| accelerated phase chronic myelogenous leukemia | View |
| blastic phase chronic myelogenous leukemia | View |
| previously treated myelodysplastic syndromes | View |
| atypical chronic myeloid leukemia BCR-ABL1 negative | View |
| myelodysplasticmyeloproliferative neoplasm unclassifiable | View |